CM Hospitalar S/A (BVMF:VVEO3)

Brazil flag Brazil · Delayed Price · Currency is BRL
1.400
+0.020 (1.45%)
Last updated: Mar 31, 2025
-78.29%
Market Cap 435.82M
Revenue (ttm) 11.57B
Net Income (ttm) -61.17M
Shares Out 315.81M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend 0.14 (9.82%)
Ex-Dividend Date May 2, 2024
Volume 438,800
Average Volume 1,482,200
Open 1.360
Previous Close 1.380
Day's Range 1.360 - 1.440
52-Week Range 1.280 - 7.400
Beta 0.08
RSI 42.13
Earnings Date Mar 27, 2025

About CM Hospitalar S/A

CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers ophthalmic agent, adrenergic and thrombopoietin agonist, aminoglycosides, painkiller, anesthetics, receptor antagonist, anti-hemorrhoidal, antihypertensives, systemic antihistamine, and orthopedic therapy materials; and anti-inflammatories, anti-TNF, antacid, antiandrogen, antianemic, anti-asthmatic, antibiotic, anticoagulant, anticonvulsant, monoclonal antibody, anti-growth, antidepressant, antidiabetic, antidiur... [Read more]

Sector Healthcare
Founded 2010
Employees 6,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol VVEO3
Full Company Profile

Financial Performance

In 2023, CM Hospitalar S/A's revenue was 11.08 billion, an increase of 26.72% compared to the previous year's 8.75 billion. Earnings were 359.92 million, an increase of 38.57%.

Financial Statements

News

There is no news available yet.